MRC Agrotech (540809)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹12.9 |
| Market Cap | ₹26.43 Cr |
| P/E Ratio | 163.04 |
| ROCE | 5.89% |
| ROE | 2.82% |
| Dividend Yield | 0% |
| Profit Growth | -25% |
| Debt/Equity | — |
| Sales Growth | 127.01% |
| 52-Week Range | ₹26.88 — ₹54.5 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹15.77 |
Strengths
- Stock trades below book value at P/B of 0.82, providing potential asset-backed downside support
- Sales grew sharply by 127%, indicating business expansion or increased trading activity
- ROCE is positive at 5.89%, showing some return on capital employed
- Low absolute market cap of ₹26 Cr may give niche flexibility if the business stabilizes
Concerns
- P/E of 163.04 and latest quarterly net profit near ₹0 Cr indicate very weak earnings power
- ROE is only 2.82% and profit growth is -25% despite booming sales, suggesting poor cost control or margins
- No dividend yield means shareholders rely entirely on price appreciation
- Current price of ₹12.90 is below the stated 52-week range of ₹26.88-₹54.50, raising data or liquidity concerns
AI Analysis
In the Graham tradition, I first look for a margin of safety. At ₹12.90, MRC Agrotech trades at only 0.82 times its book value of ₹15.77, so the market is pricing every rupee of tangible net worth at 82 paise. That would catch my eye. But a cheap price-to-book ratio is only useful if the underlying assets can earn a fair return. Here, ROE is just 2.82% and ROCE is 5.89%. The latest quarter shows sales of ₹12 Cr but net profit of roughly ₹0 Cr. This is a marginal earner, not a compounding machine. The P/E of 163.04 confirms how thin the earnings power really is. Sales growth of 127% looks exciting at first glance, yet profit actually fell 25%. That is a classic sign of a trader or distributor with revenue pass-through but no pricing power. Mr. Market has clearly repriced this stock—the current price sits well below the stated 52-week range of ₹26.88 to ₹54.50, which itself raises questions about liquidity, data frequency, or previous speculative froth. The Piotroski F-score of 4 out of 9 also suggests below-average financial health. This is not a wonderful business. It is an asset play: you are buying a rupee of book value for 82 paise, but the ability to generate sustained profits is unproven. There is no dividend yield to compensate, and promoter holding is not even disclosed. Graham would demand evidence that book value is real and that earning power can recover. Until I see consistent positive quarterly profits, better margins, and clearer capital discipline, the low P/B multiple alone is not enough. I would wait patiently—or look elsewhere.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer